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CASE REPORT / OLGU SUNUMU 
Multiple myeloma masquerading as a pulmonary mass: A rare presentation
Akciğerde bir kitle olarak maskelenen multiple miyeloma: Nadir bir ortaya çıkış
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ÖZET
Multiple miyeloma plazma hücrelerinin malign hastalığı-
dır. Plazma hücreleri vücutta yaygın olarak bulunmakla 
birlikte, tümör genellikle kemik ve kimik iliği içine yayılır. 
İlerlemiş vakalarda bile ilik dışına metasazla yayılımı na-
dirdir. Akciğer parankiminin miyelom hücrelerei tarafından 
gerek  plazmositoma  olarak  gerekse  akciğer  metastazı 
olarak tutulumu nadirdir ve hastalığın agresif terminal dö-
nemi ile ilgilidir. Burada ilk olarak akciğer parankim kitlesi 
olarak belirti veren bir multiple miyeloma olgusunu sunu-
yoruz.
Anahtar kelimeler: Akciğer, multiple miyelom, ekstrame-
duller plazmositom.
ABSTRACT
Multiple myeloma represents malignant disorder of plas-
ma cells. Tumour extension is primarily seen within the 
bone and bone marrow, despite widespread distribution 
of plasma cells in the body. Metastatic deposits outside 
bone  marrow  (extramedullary)  are  uncommon  even  in 
advanced multiple myeloma. Involvement of pulmonary 
parenchyma by myeloma cells either as plasmacytoma or 
as a pulmonary infiltrate is rare and is related to aggres-
sive terminal phase of the disease. We are reporting a 
case of multiple myeloma with a pulmonary parenchymal 
mass as the initial presenting manifestation.
Key words: Pulmonary, multiple myeloma, extramedul-
lary plasmacytoma (EMP).
INTRODUCTION
Multiple myeloma is a neoplasm of B cell lineage 
characterised by excessive proliferation of abnormal 
plasma cells involving primarily the bone marrow. 
These malignant plasma cells secrete an abnormal 
immunoglobulin causing a monoclonal gammopa-
thy.1 The disease process mainly involves the axial 
skeleton. The occurrence of extramedullary disease 
is uncommon in multiple myeloma.2 Reported ex-
tramedullary sites include liver, spleen and lymph 
nodes.3 Lung parenchymal involvement in multiple 
myeloma is extremely rare.4 The prognosis of pa-
tient with pulmonary involvement is poor and is 
more commonly associated with aggressive termi-
nal phase of myeloma.3 Here we are reporting an 
interesting case of multiple myeloma masquerading 
as a pulmonary mass with thoracic extension in-
volving D4-D8 vertebrae and adjacent ribs.
CASE
A 50 years old male presented to the department of 
Chest and Tuberculosis at Post Graduate Institute 
of Medical Sciences, Rohtak, India with a vague 
complaint of chest pain, cough and mild breathless-
ness of 6 months duration. The pain was moderate 
in  intensity  and  constant.  He  was  a  non-smoker 
and non-alcoholic. There was no history of fever 
or  preceding  trauma.  Chest  radiograph  showed  a 
peripheral shadow involving right upper and mid-
dle zone and extending beyond the thoracic cage. 
Physical  examination  of  the  patient  revealed  no 
significant abnormality except mild pallor. Routine 
investigations revealed Hb-9.6 g/dl, TLC-9800/cm3 
with  neutrophils-70%,  lymphocytes-23%,  eosino-
phils-2%, monocytes-5%. ESR was 60 mm 1st hour 
by Wintrobe method. The blood urea, serum creati-
nine, blood sugar, serum uric acid, serum bilirubin, 
SGPT, serum alkaline phosphatase, serum calcium 
and phosphorus were within normal limits. Percu-S. Singh, et al. Multiple myeloma as a pulmonary 111
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taneous  fine  needle  aspiration  cytology  (FNAC) 
and biopsy from pulmonary lesion was done which 
showed  cellular  infiltrate  comprising  mature  and 
immature  plasma  cells,  including  binucleate  and 
multinucleate forms along with pulmonary paren-
chymal cells (Fig.1 a & b). Diagnosis of plasma-
cytoma was suggested and patient was advised to 
undergo computed tomography scan, skeletal sur-
vey and electrophoresis to rule out pulmonary dis-
semination of multiple myeloma.
Figure 1 a&b. FNAC and biopsy lung: Photomicrograph revealing plasma cell infiltrate (Giemsa 400X, H 
& E 400X)
A subsequent skull radiograph revealed mul-
tiple punched out lytic lesions (Fig. 2) Contrast to-
mography (CT) examination of chest revealed large 
peripheral lung mass with smooth margins in lateral 
segment of right middle lobe showing homogenous 
contrast enhancement. The mass was extending in 
the costovertebral space of D-4 to D-8 vertebrae 
alongwith erosion of the adjacent vertebra and ribs 
(Fig. 3).
Figure 2. X-ray skull: showing multiple punched out 
lytic lesions
Figure 3. CT scan showing mass in lung extend-
ing in thoracic cage and lytic lesion in D-4 to D-8 
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Bone marrow aspiration revealed about 10% 
plasma  cells.  Serum  protein  electrophoresis  re-
vealed  normal  total  serum  proteins  (7.8gm/dl), 
mildly  raised  gamma  globulin  -1.84g/dl,  (normal 
0.6-1.6g/dl)  and  normal  serum  albumin,  alpha  1, 
alpha 2 and beta globulin. Bence Jones proteinuria 
was  absent.  Immunofixation  showed  A/G  -1.42, 
serum IgG -17.1g/dl (normal 6.94-16.2 g/dl), se-
rum IgA-2.38g//l, serum IgM -0.82 g/l, serum free 
Kappa  (light  chain)  2.50mg/dl  (normal  0.33-1.94 
mg/dl), serum free lambda (light chain) 1.03mg/dl, 
serum  free  kappa/lamda  ratio-2.42  (normal  0.26-
1.65). It showed monoclonal band in serum protein 
electrophoresis lane, corresponding to monoclonal 
band seen in IgG and Kappa lanes suggestive of 
IgG kappa monoclonal gammopathy. A final diag-
nosis of multiple myeloma with dissemination in 
pulmonary parenchyma and adjoining soft tissues 
was made.
DISCUSSION
Multiple myeloma is a haematological malignancy 
characterised by malignant clonal proliferation of 
plasma cells in the bone marrow. It is associated 
with  serum  monoclonal  protein,  skeletal  destruc-
tion with osteolytic lesions, pathological fractures, 
bone pains, hypercalcemia, renal failure, and ane-
mia. The disease spans a spectrum from localised, 
smoldering or indolent to aggressive, disseminated 
forms with plasma cell infiltration of various organs, 
plasma cell leukemia, and disorders due to deposi-
tion of abnormal immunoglobin chains in tissues. 
Generalised bone marrow involvement in multiple 
myeloma is typically present.5 Rarely in advanced 
multiple myeloma, metastatic deposits outside the 
bone marrow (extramedullary) are seen.1 Myeloma 
cells  found  at  extramedullary  site  may  either  be 
due to extramedullary plasmacytoma (EMP) or due 
to  extramedullary  dissemination  of  multiple  my-
eloma.6 EMP is uncommon and is characterised by 
discrete solitary masses of neoplastic monoclonal 
plasma cells outside bone marrow.2 Most common 
sites for solitary extramedullary plasmacytoma in-
clude mainly upper respiratory tract such as nasal 
cavities, paranasal sinuses and nasopharynx without 
the involvement of bone marrow.5 Extramedullary 
dissemination of multiple myeloma is also uncom-
mon and reported sites include spleen, liver, lymph 
nodes, kidney, thyroid gland, adrenals, ovary, testes, 
lung, pleura, pericardium, intestinal tract and skin.6 
Multiple  myeloma  masquerading  as  pulmonary 
nodule is extremely rare. Pulmonary involvement in 
myeloma is so rare that there is no mention of its oc-
currence in several large series. Kintzer et al found 
that 46% of patients in a series of 958 cases had 
thoracic involvement by myeloma. Most of them 
showed bone involvement or pulmonary infiltrate 
secondary to an infectious process. Only 11 patients 
developed extramedullary plasmacytoma in the tho-
rax and four patients had pulmonary infiltrate sug-
gestive of myeloma cell infiltrate (with only one 
proven case).7 In another study 19 (4.4%) out of 
432 patients of multiple myeloma were identified 
as having extramedullary disease, common sites be-
ing lymph node, pleura and soft tissues with only 
3 cases (6.2%) occurring within lung parenchyma.2 
Pulmonary  involvement  seems  to  be  more  com-
monly associated with aggressive terminal phase of 
myeloma.3 We report a case in which pulmonary pa-
renchymal lesion was the initial presentation of the 
disease and the diagnosis of multiple myeloma was 
confirmed subsequently on investigations.
In diagnostic criteria of multiple myeloma, ma-
jor criterias include plasmacytosis on tissue biopsy, 
bone marrow plasmacytosis > 30% plasma cells, 
monoclonal  globulin  spike  on  serum  electropho-
resis (> 3g/dl for IgG, 2 g/dl for IgA) or on urine 
electrophoresis (>1g/24hr of kappa or lamda light 
chain) while minor criterias include bone marrow 
plasmacytosis of 10-30% plasma cells, monoclonal 
globulin spike less than the level defined above, lyt-
ic bone lesions and residual normal IgM<0.05g/dl, 
IgA<0.1g/dl, IgG<0.6g/dl. The diagnosis of mul-
tiple myeloma requires a minimum of two major or 
one major and one minor criteria each or three minor 
criteria (always including 1 and 2).8 In our case, the 
major criterias included extramedullary pulmonary 
parenchymal  plasmacytoma  on  tissue  biopsy  and 
percutaneous FNAC of lung; and in minor criteria 
patient’s bone marrow aspiration showed approxi-
mately 10% plasma cells, multiple lytic lesions on 
skull radiography and abnormal monoclonal globu-
lin spike showing mild increase in serum IgG and 
serum kappa levels. These findings were suggestive 
of the diagnosis of multiple myeloma.
The pulmonary involvement in multiple my-
eloma needs to be differentiated from solitary extra-
medullary pulmonary plasmacytoma, the treatment S. Singh, et al. Multiple myeloma as a pulmonary 113
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and prognosis of the two conditions is vastly differ-
ent. The diagnostic criterias for solitary extramed-
ullary  pulmonary  plasmacytoma  are  monoclonal 
plasma cell histology on tissue biopsy, bone marrow 
plasma cell infiltration not exceeding 5% of all nu-
cleated cells, absence of osteolytic bone lesions or 
other tissue involvement, absence of hypercalcemia 
or renal failure, low serum M protein concentration, 
if present.9
The  most  typical  thoracic  manifestations  of 
multiple myeloma are bony involvement of thoracic 
cage or pulmonary infiltrate secondary to infection. 
Other described manifestations of myeloma in the 
lungs include multiple nodular lesions, diffuse re-
ticulonodular  pattern,  pulmonary  calcification  or 
amylodosis.2
Multiple myeloma masquerading as pulmonary 
mass at its first presentation prompted us to put for-
ward this case report.
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